Detalles de la búsqueda
1.
A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction.
Invest New Drugs
; 30(4): 1684-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21863238
2.
Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer.
Oral Oncol
; 103: 104585, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32044714
3.
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes.
J Gastrointest Cancer
; 48(2): 181-189, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27734205
4.
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.
J Gastrointest Oncol
; 7(2): 196-205, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034786
5.
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.
Head Neck
; 37(11): 1583-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24909549
6.
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
J Thorac Oncol
; 9(10): 1561-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25170643
7.
Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck.
Head Neck
; 34(11): 1517-23, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22180262
8.
Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly.
Head Neck
; 34(8): 1147-52, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021098
9.
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
J Thorac Oncol
; 5(2): 229-35, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20009775
10.
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
J Thorac Oncol
; 4(10): 1264-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19668013
Resultados
1 -
10
de 10
1
Próxima >
>>